Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells.
Drugs such as amifostine may prevent the side effects of radiation therapy. Combining more
than one drug and combining radiation therapy and surgery with chemotherapy may kill more
tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining surgery, radiation therapy,
and combination chemotherapy in treating patients who have recurrent head and neck cancer
that has been treated previously with radiation therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania University of Pennsylvania